Cytek Biosciences (CTKB) Leases (2022 - 2025)
Historic Leases for Cytek Biosciences (CTKB) over the last 4 years, with Q3 2025 value amounting to $11.2 million.
- Cytek Biosciences' Leases rose 1021.34% to $11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 1021.34%. This contributed to the annual value of $10.2 million for FY2024, which is 631.16% down from last year.
- Cytek Biosciences' Leases amounted to $11.2 million in Q3 2025, which was up 1021.34% from $16.4 million recorded in Q2 2025.
- In the past 5 years, Cytek Biosciences' Leases ranged from a high of $16.4 million in Q2 2025 and a low of $9.3 million during Q2 2024
- In the last 4 years, Cytek Biosciences' Leases had a median value of $11.7 million in 2023 and averaged $12.1 million.
- Its Leases has fluctuated over the past 5 years, first plummeted by 2491.35% in 2024, then soared by 7567.54% in 2025.
- Cytek Biosciences' Leases (Quarter) stood at $13.9 million in 2022, then fell by 21.83% to $10.9 million in 2023, then fell by 6.31% to $10.2 million in 2024, then grew by 9.74% to $11.2 million in 2025.
- Its last three reported values are $11.2 million in Q3 2025, $16.4 million for Q2 2025, and $9.9 million during Q1 2025.